Antiparallel β ‐Sheet as a Key Motif of Amyloid‐ β Inhibitor Designed via Topological Peptide Reprogramming
Angewandte Chemie International Edition · 07.07.2025 · 64 (28)
DOI: 10.1002/anie.202504640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 22.05.2025. Verfasst von Dongjoon Im und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Korea University, Seoul, 02841, Republic of Korea. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Peptides, Peptide Fragments. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health & Welfare (MOHW), Ministry of Science and ICT (MSIT), NHLBI NIH HHS, Ministry of Science and ICT.
Abstract (Originalsprache)
Peptide inhibitor design targeting self‐assembly of amyloid‐ β (A β ) represents a promising strategy for suppressing the pathogenic mechanism of Alzheimer's disease (AD). Conventional approaches have primarily mimicked repetitive sequences found in fibrillar structures of A β aggregates. However, since the inherent flexibility of A β structures promotes the structural changes in the early‐stage oligomerization, a structural modulation should be considered in the design of peptide inhibitors. Herein, we introduce topological reprogramming of peptides to control the structural transformation in pathogenic A β 1–42 (A β 42). The eleven‐residue peptide scaffold P a11 ( 14 HQKLVNFAEDV 24 ) identified through the initial screening was dimerized via a disulfide bond. The dimerization stabilizes A β 42 into higher order structures by promoting antiparallel β ‐sheet conformations, thereby significantly suppressing A β 42 aggregation. Our approach underscores that modification in peptide connectivity would be a breakthrough for controlling the intrinsic flexibility of A β , surpassing the limitation in conventional, one‐dimensional peptide building block.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Korea University, Seoul, 02841, Republic of Korea.
- Division of Chemistry and Chemical Engineering and Materials Process and Simulation Center, California Institute of Technology, Pasadena, CA 91125, USA.
- Department of Life Sciences, Korea University, Seoul, 02841, Republic of Korea.
- Center for Proteogenome Research, Korea University, Seoul, 02841, Republic of Korea.
- Center for Mechanogenome Research, Korea University, Seoul, 02841, Republic of Korea.
Förderung
- Ministry of Health & Welfare (MOHW), Ministry of Science and ICT (MSIT)
- NHLBI NIH HHS
- Ministry of Science and ICT
- Yuhan
- NIH HHS
- Ministry of Education
- National Institutes of Health
- Ministry of Science and ICT, South Korea
Zitieren
APA
Im, D., Lee, Y. E., Yoon, G., Goddard, W. A., Choi, T. S., & Kim, H. I. (2025). Antiparallel β ‐Sheet as a Key Motif of Amyloid‐ β Inhibitor Designed via Topological Peptide Reprogramming. Angewandte Chemie International Edition, 64(28). https://doi.org/10.1002/anie.202504640
Vancouver
Im D, Lee YE, Yoon G, Goddard WA, Choi TS, Kim HI. Antiparallel β ‐Sheet as a Key Motif of Amyloid‐ β Inhibitor Designed via Topological Peptide Reprogramming. Angewandte Chemie International Edition. 2025;64(28). doi:10.1002/anie.202504640
BibTeX
@article{Im2025,
author = {Im, Dongjoon and Lee, Ye Eun and Yoon, Gyusub and Goddard, William A and Choi, Tae Su and Kim, Hugh I},
title = {Antiparallel β ‐Sheet as a Key Motif of Amyloid‐ β Inhibitor Designed via Topological Peptide Reprogramming},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {28},
doi = {10.1002/anie.202504640}
}
EUVIMED